Haze and dengue: the unanswered questions.

“Current Dengue Vaccine Status”

As the impact of dengue expands, a safe and effective vaccine will benefit the world greatly. Recent progress and novel approaches have advanced the field, but many challenges and unanswered questions remain for dengue vaccine developers. The most advanced dengue vaccine candidate, a chimeric yellow fever dengue (CYD) tetravalent vaccine, was the first dengue vaccine tested in a field efficacy ...

Quantitative Analyses of Mosquito Biology, Disease, and Control by GMM

very low population densities because they preferentially and frequently bite humans (23). A successful GMM dengue control program that falls short of vector eradication will result in a reduction in human herd immunity and a corresponding decrease in already low transmission threshold levels. Because there is no commercially available vaccine or clinical cure for dengue, predicting and testing...

E-Learning: some unanswered questions

Prevention and Control Policies of Dengue Vectors (Aedes aegypti and albopictus) in Iran

Background and Objective: Dengue fever has become a major public health problem in many world regions due to increased trade, travel, and problems controlling Aedes vectors. This policy brief aims to review, analyze, and present evidence-based policies for dengue prevention and control. Methods: The present research is a compilation of a policy brief in Iran, carried out in 3 stages according ...

Clinicohematological Profiles of Hospitalized Patients with Dengue in Kolkata in 2012 Epidemic, West Bengal

Dengue usually presents itself with subclinical or mild infection to full blown dengue fever (DF) to dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). In Kolkata, dengue started in 1824 followed by five epidemics that occurred in 1836, 1906, 1911, 1923 and 2005. The aim of this investigation is to study the clinicohematological correlation of all patients with respect to their gen...